Victory Capital Management
INO icon

Victory Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

Victory Capital Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,406
Closed -$11.2K – 2576
2023
Q3 		$11.2K Buy
2,406
+80
+3% +$442 ﹤0.01% 2480
2023
Q2 		$12.5K Sell
2,326
-54
-2% -$435 ﹤0.01% 2477
2023
Q1 		$23.4K Buy
2,380
+68
+3% +$1.16K ﹤0.01% 2498
2022
Q4 		$43.3K Sell
2,312
-1
-0% -$23 ﹤0.01% 2466
2022
Q3 		$48K Sell
2,313
-181
-7% -$4.63K ﹤0.01% 2571
2022
Q2 		$52K Buy
2,494
+188
+8% +$5.3K ﹤0.01% 2549
2022
Q1 		$76K Sell
2,306
-66
-3% -$2.97K ﹤0.01% 2553
2021
Q4 		$142K Sell
2,372
-73
-3% -$5.85K ﹤0.01% 2529
2021
Q3 		$210K Sell
2,445
-99
-4% -$9.94K ﹤0.01% 2509
2021
Q2 		$283K Sell
2,544
-98
-4% -$9.41K ﹤0.01% 2436
2021
Q1 		$294K Sell
2,642
-652
-20% -$85.7K ﹤0.01% 2406
2020
Q4 		$350K Sell
3,294
-741
-18% -$98.7K ﹤0.01% 2226
2020
Q3 		$562K Buy
4,035
+1,023
+34% +$213K ﹤0.01% 1912
2020
Q2 		$974K Sell
3,012
-734
-20% -$118K ﹤0.01% 1745
2020
Q1 		$334K Buy
3,746
+650
+21% +$40.1K ﹤0.01% 2214
2019
Q4 		$123K Buy
3,096
+1,728
+126% +$52K ﹤0.01% 2476
2019
Q3 		$34K Buy
+1,368
New +$41.6K ﹤0.01% 2852

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management's INO Position: Q4 2023 in Review

Victory Capital Management sold out of Inovio Pharmaceuticals (INO) in Q4 2023, closing a stake of 2,406 shares — an estimated $11.2K sold.

Victory Capital Management first reported a position in INO in Q3 2019 and held it in 17 quarters. The position peaked at $974K in Q2 2020. 113 funds tracked by Wall St. Rank hold INO as of Q4 2023.

  • Victory Capital Management reported no remaining Inovio Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Victory Capital Management sold 2,406 Inovio Pharmaceuticals shares in Q4 2023, an estimated $11.2K.
  • Victory Capital Management first reported a position in Inovio Pharmaceuticals in Q3 2019 and held it in 17 quarters.
  • Victory Capital Management's Inovio Pharmaceuticals position peaked at $974K in Q2 2020.
  • 113 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2023.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.